🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a global, randomized, double-blind, placebo-controlled, multicenter...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2020-08-12
Trial ID
NCT04322539
Treatments Being Tested
This is an international, multicenter, open-label, randomized, Phase 3 stud...
Status
Completed
Location
Local Institution - 121
Start Date
2015-12-30
Trial ID
NCT02577406
Treatments Being Tested
This is a 2-arm, prospective, randomized (2:1 ratio), open-label, multi-cen...
Status
Completed
Location
Azienda Sanitaria Locale CN2 - Alba e Bra
Start Date
2019-08-27
Trial ID
NCT03945084
Treatments Being Tested
The study's hypothesis is that using Nivolumab as early switch maintenance,...
Status
Unknown
Location
UOC Oncologia - Azienda USL di Imola - Ospedale Santa Maria della Scaletta
Start Date
2017-09-25
Trial ID
NCT03542461
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of oral ma...
Status
Unknown
Location
Centre Hospitalier Universitaire d'Amiens
Start Date
2020-07-01
Trial ID
NCT04333108
Treatments Being Tested
The purpose of the study is to evaluate the efficacy and safety of luspater...
Status
Recruiting
Location
Local Institution - 0008
Start Date
2022-12-09
Trial ID
NCT05664737
Treatments Being Tested
To evaluate the efficacy and safety of two dosing schemes of oral masitinib...
Status
Unknown
Location
St Charles Clinical Research
Start Date
2022-07-01
Trial ID
NCT05449444
Treatments Being Tested
The objective of this Phase III study is to evaluate the efficacy of ninted...
Status
Completed
Location
1199.52.0108 Boehringer Ingelheim Investigational Site
Start Date
2014-09-25
Trial ID
NCT02149108
Treatments Being Tested
The primary objective of this study is to compare overall survival (OS) in ...
Status
Completed
Location
Virginia G. Piper Cancer Center
Start Date
2010-11
Trial ID
NCT01241500
Treatments Being Tested
This randomized, double-blind, multi-center Phase IIb/III trial will be per...
Status
Completed
Location
1200.23.038 Boehringer Ingelheim Investigational Site
Start Date
2008-04
Trial ID
NCT00656136